GitLab Analysts Slash Their Forecasts After Q1 Results

GitLab (GTLB) reported Q1 earnings of $0.17 per share on revenue of $214.51 million, exceeding analyst estimates, while Q2 revenue guidance of $226-$227 million fell slightly below the $227.16 million consensus. Despite the earnings beat, several analysts lowered their price targets on GitLab, citing valuation concerns, with Needham reducing its target to $55 from $85; the stock closed down 0.3% at $48.51.

Analysis

GitLab, Inc. (GTLB) reported first-quarter fiscal year 2026 earnings of 17 cents per share, surpassing the analyst consensus estimate of 15 cents, and quarterly revenue of $214.51 million, which also exceeded the Street estimate of $213.16 million. CEO Bill Staples attributed this performance to the strength of GitLab's AI-native DevSecOps platform. However, the company's second-quarter revenue guidance, projected between $226 million and $227 million, has a midpoint slightly below the $227.16 million analyst estimate, while its adjusted EPS guidance of 16 to 17 cents brackets the 16 cent estimate. Reflecting a cautious market sentiment, GitLab shares declined 0.3% to $48.51 following the announcement. Notably, multiple analysts revised their price targets downwards despite the earnings beat: Needham lowered its target from $85 to $55 (maintaining Buy), BTIG from $86 to $67 (maintaining Buy), Wells Fargo from $65 to $60 (maintaining Overweight), UBS from $85 to $73 (maintaining Buy), Scotiabank from $67 to $60 (maintaining Sector Outperform), and JP Morgan from $58 to $52 (maintaining Neutral). This collective action from analysts, despite generally positive ratings, suggests concerns possibly linked to the softer revenue outlook or prevailing valuation metrics in the current market environment, contributing to an overall mixed sentiment score of -0.25 for the stock.

Key Decisions for Investors

• Investors should weigh GitLab's consistent earnings outperformance against the slightly cautious Q2 revenue guidance and the significant downward revisions in price targets from multiple analysts.
• Monitor the company's ability to achieve its Q2 revenue targets, as this will be a key indicator of its growth trajectory amid analyst concerns.
• Consider the broad analyst consensus on maintaining buy or outperform ratings, albeit at lower price targets, suggesting underlying confidence in the long-term business model but moderated near-term expectations.
• Evaluate the CEO’s optimistic statements regarding AI-driven innovation against the market's immediate negative share price reaction and the cautious analyst outlooks before adjusting positions.